Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 4 , Pages 639-657, August 2008

Acromegaly, growth hormone and cancer risk

  • Andrew G. Renehan, PhD, FRCS (Doctor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Department of Surgery, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK. Tel.: +44 161 446 3157; Fax: +44 161 446 3365.

School of Cancer and Imaging Sciences, University of Manchester, Manchester, UK

Department of Surgery, Christie Hospital NHS Foundation Trust, Wilmslow Road, Manchester M20 4BX, UK

Department of Paediatric Oncology, Central Manchester and Manchester Children's University Hospitals NHS Trust, Manchester, UK

Young Oncology Unit, Christie Hospital NHS Foundation Trust, Manchester, UK

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(08)00097-3

doi:10.1016/j.beem.2008.08.011

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 4 , Pages 639-657, August 2008

Article Tools

* Image Usage & Resolution